Company intelligence / Profile preview

Trubion Pharmaceuticals

Seattle, Washington, United Statestrubion.com ↗

Ownership: Private
Development stage: Preclinical

Overview

At the time of its acquisition by Emergent BioSolutions in late 2010, Trubion had multiple advanced-stage candidates for oncology and autoimmunity. Its lead program was a CD20-targeted therapy for rheumatoid arthritis developed using its proprietary SMIP platform. The company also had additional clinical-stage and preclinical assets targeting major unmet needs in inflammation and cancer. No commercial products were on the market at the time of acquisition.

Therapeutic areas: OncologyImmunology
Modalities: monoclonal antibodies (mAbs)SMIP™ (Small Modular ImmunoPharmaceuticals) protein therapeutics
Industry: Biotech

Partnerships

Wyeth Pharmaceuticals – strategic collaboration on CD20-targeted therapies including co-development/commercialization rights with potential deal value exceeding $800 million if milestones achieved; Wyeth received worldwide rights to certain products from Trubion's discovery program.

Beyond the preview

Go deeper on Trubion Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trubion Pharmaceuticals.

Explore the full profile